Editor's Note :

Editor's Note :

We expect orders from the February 17 conference on Tuesday at 9:30 a.m. There is a possibility of opinions on Wednesday, February 22.

Merck & Co. v. Louisiana Wholesale Drug Company, Inc.

Pending petition

Linked with:

Docket No. Op. Below Argument Opinion Vote Author Term
12-245 3d Cir. TBD TBD TBD TBD TBD
 
Share:

Disclosure: Goldstein & Russell, P.C., whose attorneys work for or contribute to this blog in various capacities, serves as co-counsel to the respondents in this case, which is listed without regard to its likelihood of being granted.

Issue: Whether the federal antitrust laws permit a brand-name manufacturer that holds the patent for a drug to enter into a settlement of patent litigation with a prospective generic manufacturer, where the settlement includes a payment from the brand manufacturer to the generic manufacturer but does not exclude competition beyond the scope of the patent.

Plain English Summary:

SCOTUSblog Coverage

Briefs and Documents

Certiorari-stage documents

Term Snapshot
Awards